NewslettersCancer Stem Cell NewsLysosomal Acid Lipase a Modulates Leukemia Stem Cell Response to Venetoclax/Tyrosine Kinase Inhibitor Combination Therapy in Blast Phase Chronic Myeloid LeukemiaBy lbeveridge - July 3, 2024099Investigators employed preclinical models of blast phase chronic myeloid leukemia to investigate the efficacy and underlying mechanism of leukemia stem cells-targeting with venetoclax/TKI combinations.[Haematologica]Abstract